Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project.

Schliess F, Heise T, Benesch C, Mianowska B, Stegbauer C, Broge B, Gillard P, Binkley G, Crône V, Carlier S, Delval C, Petkov A, Beck JP, Lodwig V, Gurdala M, Szecsenyi J, Rosenmöller M, Cypryk K, Mathieu C, Renard E, Heinemann L.

J Diabetes Sci Technol. 2019 Mar;13(2):261-267. doi: 10.1177/1932296818803588. Epub 2018 Sep 21.

PMID:
30241444
2.

Impact of insulin glargine and lixisenatide on β-cell function in patients with type 2 diabetes mellitus: A randomized open-label study.

Meier JJ, Schenker N, Kahle M, Schliess F, Kapitza C, Menge BA.

Diabetes Obes Metab. 2017 Nov;19(11):1625-1629. doi: 10.1111/dom.12968. Epub 2017 May 31.

PMID:
28407415
3.

Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.

Muscelli E, Astiarraga B, Barsotti E, Mari A, Schliess F, Nosek L, Heise T, Broedl UC, Woerle HJ, Ferrannini E.

Diabetologia. 2016 Apr;59(4):700-8. doi: 10.1007/s00125-015-3845-8. Epub 2015 Dec 24.

PMID:
26704626
4.

Effects of dextromethorphan as add-on to sitagliptin on blood glucose and serum insulin concentrations in individuals with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blinded, multiple crossover, single-dose clinical trial.

Marquard J, Stirban A, Schliess F, Sievers F, Welters A, Otter S, Fischer A, Wnendt S, Meissner T, Heise T, Lammert E.

Diabetes Obes Metab. 2016 Jan;18(1):100-3. doi: 10.1111/dom.12576. Epub 2015 Oct 26.

5.

Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment.

Marquard J, Otter S, Welters A, Stirban A, Fischer A, Eglinger J, Herebian D, Kletke O, Klemen MS, Stožer A, Wnendt S, Piemonti L, Köhler M, Ferrer J, Thorens B, Schliess F, Rupnik MS, Heise T, Berggren PO, Klöcker N, Meissner T, Mayatepek E, Eberhard D, Kragl M, Lammert E.

Nat Med. 2015 Apr;21(4):363-72. doi: 10.1038/nm.3822. Epub 2015 Mar 16.

PMID:
25774850
6.

Upper gastrointestinal motility and symptoms in individuals with diabetes, prediabetes and normal glucose tolerance.

Boronikolos GC, Menge BA, Schenker N, Breuer TG, Otte JM, Heckermann S, Schliess F, Meier JJ.

Diabetologia. 2015 Jun;58(6):1175-82. doi: 10.1007/s00125-015-3538-3. Epub 2015 Mar 1.

PMID:
25725624
7.

Integrated metabolic spatial-temporal model for the prediction of ammonia detoxification during liver damage and regeneration.

Schliess F, Hoehme S, Henkel SG, Ghallab A, Driesch D, Böttger J, Guthke R, Pfaff M, Hengstler JG, Gebhardt R, Häussinger D, Drasdo D, Zellmer S.

Hepatology. 2014 Dec;60(6):2040-51. doi: 10.1002/hep.27136. Epub 2014 May 12.

8.

O-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes.

Karababa A, Görg B, Schliess F, Häussinger D.

Metab Brain Dis. 2014 Dec;29(4):975-82. doi: 10.1007/s11011-013-9454-7. Epub 2013 Dec 1.

PMID:
24292976
9.

Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.

Görg B, Schliess F, Häussinger D.

Arch Biochem Biophys. 2013 Aug 15;536(2):158-63. doi: 10.1016/j.abb.2013.03.010. Epub 2013 Apr 6.

PMID:
23567841
10.

Osmotic regulation of hepatic betaine metabolism.

Hoffmann L, Brauers G, Gehrmann T, Häussinger D, Mayatepek E, Schliess F, Schwahn BC.

Am J Physiol Gastrointest Liver Physiol. 2013 May 1;304(9):G835-46. doi: 10.1152/ajpgi.00332.2012. Epub 2013 Feb 28.

11.

Ammonia increases nitric oxide, free Zn(2+), and metallothionein mRNA expression in cultured rat astrocytes.

Kruczek C, Görg B, Keitel V, Bidmon HJ, Schliess F, Häussinger D.

Biol Chem. 2011 Dec;392(12):1155-65. doi: 10.1515/BC.2011.199.

PMID:
22050230
12.

RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Schliess F, Görg B, Häussinger D.

Metab Brain Dis. 2009 Mar;24(1):119-34. doi: 10.1007/s11011-008-9125-2. Epub 2009 Jan 16. Review.

PMID:
19148713
13.

Hypoosmotic swelling affects zinc homeostasis in cultured rat astrocytes.

Kruczek C, Görg B, Keitel V, Pirev E, Kröncke KD, Schliess F, Häussinger D.

Glia. 2009 Jan 1;57(1):79-92. doi: 10.1002/glia.20737.

PMID:
18709649
14.

Glutamine synthetase is essential for proliferation of fetal skin fibroblasts.

Vermeulen T, Görg B, Vogl T, Wolf M, Varga G, Toutain A, Paul R, Schliess F, Häussinger D, Häberle J.

Arch Biochem Biophys. 2008 Oct 1;478(1):96-102. doi: 10.1016/j.abb.2008.07.009. Epub 2008 Jul 17.

PMID:
18662667
15.

Pathogenetic mechanisms of hepatic encephalopathy.

Häussinger D, Schliess F.

Gut. 2008 Aug;57(8):1156-65. doi: 10.1136/gut.2007.122176. Review.

PMID:
18628377
16.

Ammonia induces RNA oxidation in cultured astrocytes and brain in vivo.

Görg B, Qvartskhava N, Keitel V, Bidmon HJ, Selbach O, Schliess F, Häussinger D.

Hepatology. 2008 Aug;48(2):567-79. doi: 10.1002/hep.22345.

PMID:
18506841
17.

Taurolithocholic acid-3 sulfate impairs insulin signaling in cultured rat hepatocytes and perfused rat liver.

Mannack G, Graf D, Donner MM, Richter L, Gorg B, Vom Dahl S, Haussinger D, Schliess F.

Cell Physiol Biochem. 2008;21(1-3):137-50. doi: 10.1159/000113756. Epub 2008 Jan 16.

18.

Osmosensing and signaling in the regulation of mammalian cell function.

Schliess F, Reinehr R, Häussinger D.

FEBS J. 2007 Nov;274(22):5799-803. Epub 2007 Oct 17. Review.

19.

Osmosensing by integrins in rat liver.

Schliess F, Häussinger D.

Methods Enzymol. 2007;428:129-44. Review.

PMID:
17875415
20.

Modulation of gene expression profiles by hyperosmolarity and insulin.

Schäfer C, Gehrmann T, Richter L, Keitel V, Köhrer K, Häussinger D, Schliess F.

Cell Physiol Biochem. 2007;20(5):369-86. Erratum in: Cell Physiol Biochem. 2008;21(5-6):499.

Supplemental Content

Loading ...
Support Center